Ledger.Open graph →
SEC Form D · filed March 26, 2021

Jaguar Health, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Michelle D. Spreitzer · Farmington Hills, MIExecZiqiang Tang · Berkeley, CADirectorPeter Henn · Farmington Hills, MIDirectorMichael Mccormick · New York, NYDirectorMclain Southworth · Palo Alto, CADirectorJonathan B. Siegel · San Francisco, CADirectorJohn Micek, Iii · San Francisco, CADirectorMichael Englander · New York, NYDirectorMichael Kramarz · New York, NYExecMorton Wendell · New York, NYDirectorJonathan Wolin · San Francisco, CAExecGreg J. Divis · San Francisco, CADirectorCraig E. Walters · Ft. Worth., TXExec · Director · PromoterJoseph Guzel · Palo Alto, CADirectorJames Bochnowski · San Francisco, CADirectorBrian T. Stevens · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecCarol Lizak · San Francisco, CAExecBlake Dube · Pittsburgh, PAExec · Director · PromoterEgen Atkinson · New York, NYExecGilles J. De Vignemont · Summit, NJExecLisa Conte · San Francisco, CAExec · Director · PromoterJulie O'Hara · New York, NYDirectorSteven King · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗